Cargando…
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
Complement C1q is part of the C1 macromolecular complex that mediates the classical complement activation pathway: a major arm of innate immune defense. C1q is composed of A, B, and C chains that require post-translational prolyl 4-hydroxylation of their N-terminal collagen-like domain to enable the...
Autores principales: | Kiriakidis, Serafim, Hoer, Simon S., Burrows, Natalie, Biddlecome, Gloria, Khan, Moddasar N., Thinnes, Cyrille C., Schofield, Christopher J., Rogers, Norma, Botto, Marina, Paleolog, Ewa, Maxwell, Patrick H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612014/ https://www.ncbi.nlm.nih.gov/pubmed/28506759 http://dx.doi.org/10.1016/j.kint.2017.03.008 |
Ejemplares similares
-
Structure and Mechanism of a Viral Collagen Prolyl
Hydroxylase
por: Longbotham, James E., et al.
Publicado: (2015) -
Structure of the Ribosomal Oxygenase OGFOD1 Provides Insights into the Regio- and Stereoselectivity of Prolyl Hydroxylases
por: Horita, Shoichiro, et al.
Publicado: (2015) -
Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding
por: Thinnes, Cyrille C., et al.
Publicado: (2019) -
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in
lymphoma
por: Hatzimichael, E, et al.
Publicado: (2012) -
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
por: Yeh, Tzu-Lan, et al.
Publicado: (2017)